N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide manufacturers
- Kras4B G12D-IN-1
-
- $93.00
-
2026-07-27
- CAS:2042365-85-3
- Purity: 99.90%
- Supply Ability: 10g
|
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Basic information |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Chemical Properties |
| Boiling point | 558.0±60.0 °C(Predicted) | | density | 1.287±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 10.42±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Usage And Synthesis |
| Uses | Kras4B G12D-IN-1 is a Kras4B G12D inhibitor with anticancer effects. Kras4B G12D-IN-1 decreases Kras protein expression in mouse embryonic fibroblasts (MEF) expressing Kras4B G12D (WO2016179558A1, Comp 994566)[1]. | | IC 50 | KRas G12D | | References | [1] Frank Mccormick, et al. K-ras modulators. WO2016179558A . |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Preparation Products And Raw materials |
|
|
Tag:N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide(2042365-85-3)
Related Product Information
|
|
N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide
2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]-
2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)-
NAV2729
RMC6291
RMC-7977
|